Tenderwize
Retour à la recherche

Open House Biologics Discount Agreements 2026 - Epoetin theta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 30, 2028 · 674 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 16 Epoetin theta

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

30 / 100

Facteurs de risque

No guaranteed turnover; actual demand depends on prescriptions and market share.

Requirement for qualified electronic signature or original signed copy may cause delays.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Conclusion of discount agreements for Epoetin theta
  • Non-exclusive framework of uniform conditions
Afficher le résumé complet

Open House procedure by Techniker Krankenkasse and associated health insurers to conclude discount agreements (Rabattverträge) for the active substance Epoetin theta. All eligible pharmaceutical entrepreneurs can join at any time during the contract period (July 1, 2026 to June 30, 2028). No exclusivity, no individual negotiations, uniform conditions. The notice clarifies this is not a public procurement contract under EU Directive 2014/24/EU.

Risques

No guaranteed turnover; actual demand depends on prescriptions and market share.

Requirement for qualified electronic signature or original signed copy may cause delays.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG
  • Valid marketing authorization for the offered medicinal product
  • Seat in Germany, EU, or EEA

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria are applied; contracts are concluded with all eligible participants.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Biologics Discount Agreements 2026 - Epoetin theta

Conclusion of discount agreements for the active substance Epoetin theta under § 130a Abs. 8 SGB V. Open to all eligible pharmaceutical entrepreneurs throughout the contract period.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Jun 2026 - Jun 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria are applied; contracts are concluded with all eligible participants.

Date limite

Deadline Jun 30, 2028

Détails de la procédure

Date de publication
18 May 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
342625-2026

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3